IRIS
PROTO, CLAUDIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 224
EU - Europa 189
AS - Asia 43
Totale 456
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 224
SE - Svezia 63
IE - Irlanda 60
CN - Cina 40
FR - Francia 15
IT - Italia 13
FI - Finlandia 9
AT - Austria 8
UA - Ucraina 7
DE - Germania 6
GB - Regno Unito 4
BE - Belgio 3
IN - India 3
CZ - Repubblica Ceca 1
Totale 456
Salva come PNG Salva come JPEG
Città #
Dublin 59
Chandler 57
Nyköping 24
Beijing 19
Jacksonville 19
Ann Arbor 18
Dearborn 10
New York 10
Ashburn 8
Cambridge 8
Princeton 8
Vienna 8
Boardman 7
Medford 7
Des Moines 5
Woodbridge 5
Messina 4
Wilmington 4
Brussels 3
Hangzhou 3
Jinan 3
Pune 3
San Mateo 3
Zhengzhou 3
Lanzhou 2
Tianjin 2
Augusta 1
Guangzhou 1
Helsinki 1
Jiaxing 1
Kunming 1
Leawood 1
Monmouth Junction 1
Nanjing 1
Olomouc 1
Philadelphia 1
Ratoath 1
Shenyang 1
Taizhou 1
Totale 315
Salva come PNG Salva come JPEG
Nome #
Folate pathway implications in advanced Non Small Cell Lung Cancer (NSCLC): impact of thymidylate synthase (TS) promoter and methlylenetetrahydrofolate reductase (MTHFR) C677T and A1298C variants expression on patients’ outcome and correlation with p53 codon 72 mutations. 74
Activity of pegylated liposomal doxorubicin in combination with gemcitabine in triple negative breast cancer with skin involvement: Two case reports. 74
Second-line therapy in advanced non-small cell lung cancer: Cytotoxic agents or tyrosine kinase inhibitors? Our experience. 67
Predicting sensitivity of non small cell lung cancer to gefitinib and erlotinib: is there still a role for clinical factors ? 58
Epidermal growth factor receptor (EGFR) G719C mutation as new determinant of long term survival and response in patients with non small cell lung cancer treated with erlotinib: a case report. 51
New biomarkers to predict response to pemetrexed-based chemotherapy in non small cell lung cancer: from 5,10-methylenetetrahydrofolate reductase promises to miRNAs revolution. 48
Impact of circulating microRNAs mir-22, mir-24 and mir-34a on response to pemetrexed in patients with non small cell lung cancer 46
Uncommon breast metastatic site and eribulin responsiveness in a heavily pretreated patient 42
Totale 460
Salva come PNG Salva come JPEG
Categoria #
all - tutte 1.571
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.571
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 0 1
2019/202068 6 1 2 0 2 13 10 7 2 5 20 0
2020/202158 6 1 11 6 4 5 1 0 1 6 12 5
2021/202261 1 9 0 2 0 0 4 3 0 19 6 17
2022/2023184 11 22 6 12 15 25 3 13 72 0 4 1
2023/202441 1 11 4 4 3 14 3 0 0 0 1 0
Totale 460